Benitec Biopharma Limited to Appoint Jerel A. Banks to the Board
October 23, 2016 at 07:06 pm
Benitec Biopharma Limited announced that Jerel A. Banks, M.D., Ph.D, the Chief Investment Officer of NantVentures, will be appointed to the Board of the company and will offer himself for re-election at Benitec's upcoming annual general meeting. Prior to joining NantVentures, Dr. Banks served as vice president, portfolio manager and research analyst for the Franklin Biotechnology Discovery Fund at Franklin Templeton Investments.